新科学想法 › 文献管理 › 浏览文献

Systems biology: an evolving approach in drug discovery and development

热1 xbinbzy 添加于 2010-4-16 21:02 | 1792 次阅读 | 0 个评论

作者
Ho RL, Lieu CA
摘要
Investments in systems biology approaches by the pharmaceutical industry have not yet yielded the payoffs envisaged by many. In most cases, a plethora of novel drug targets arising from genomics led to many more failed projects in the pipeline, suggesting that target-based drug discovery may not be an optimal strategy for the industry. Before high-throughput '-omics' technologies and computer analysis became commonplace, most drug candidates were laboriously screened in animal systems to identify compounds that produced useful responses. Interestingly, the targets of many of the compounds that became drugs are still uncertain to this day. It is likely that drugs act on multiple targets in concert over time, the identification of which will require not only system level cataloguing and measurements, but next generation multiscale systems modelling. The concept of a 'differentiated drug response'- elucidating and integrating responses composed of a range of effects on different tissues and, importantly, different time scales - may eventually prove to be the dominant paradigm of systems biology research. In this article, we explore key relevant concepts and technologies that we believe are critical for the future of systems biology and its place in pharmaceutical research.
详细资料
- 关键词: Computer Simulation; Drug Design; Drug Industry/*trends; Models, Theoretical; Pharmacology/*trends; Systems Biology/*trends
- 文献种类:期刊
- 期刊名称: Drugs in R&D
- 期刊缩写: Drugs R D
- 期卷页: 2008年第9卷第4期 203-216页
- 地址: Rosa & Co., La Jolla, California, USA
- ISBN: 1174-5886
- 备注:PMID:18588352
相关链接 URL